Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that both in silico and bench testing confirmed…
Author: admin
Interstitial Cystitis Drugs Market Size to grow by USD 283.95 million | Market Insights highlight the high prevalence of interstitial cystitis as key driver
According to the research report “Interstitial Cystitis Drugs Market by Type and Geography – Forecast and…
AMID OMICRON SURGE, 1 MINUTE DISINFECTANT ADDED TO EPA’S LIST N AFTER SUCCESS IN MULTIPLE SECTORS, INCLUDING HEALTHCARE AND EDUCATION
Today, R-Water announces the success of TK60, the one minute disinfectant produced by their patented device, being included…
Sameday Health Hiring 1,000 Nurses To Support Country-Wide Clinic Expansion & Launch of House Calls Service
Sameday Health, a leading COVID testing organization and premium healthcare provider, is expanding its medical operations…
Housatonic Partners Invests in Mobile Vascular Physicians
Housatonic Partners, a growth-oriented private equity firm focused on investing in market-leading services companies, announced a…
Tampa General Hospital and USF Health Start the New Year by Moving Forward with Enhanced Alliance
Tampa General Hospital and USF Health announced that on Jan. 1, 2022, they officially launched USF Tampa General Physicians (USFTGP), a…
GT Biopharma Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on…
Petros Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference and the Biotech Showcase 2022
Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President…
Azenta Life Sciences Names Matthew McManus Chief Operating Officer
Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th. In this…
Dynacure Receives Fast Track Designation for DYN101, an Investigational Antisense Oligonucleotide for the Treatment of Myotubular and Centronuclear Myopathies
Dynacure, a clinical stage biotechnology company focusing on Myotubular and Centronuclear Myopathies (CNM), a group of…